Antonio Lizano Joins Sunlight Solutions as Regional Director for LATAM to Lead Expansion and Regional Growth
23 janv. 2025 13h04 HE
|
Sunlight Solutions
ORLANDO, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Sunlight Solutions, a leading innovator in a scalable software solution for insurance companies, proudly announces the appointment of Antonio Lizano...
Sunlight Solutions Unveils Innovative Updates: Streamlined UI, AI Enhancements, and Global Features
13 janv. 2025 08h00 HE
|
Sunlight Solutions
Sunlight Solutions' update introduces AI assistance, an optimized UI, and global features to streamline workflows and enhance user support.
Sunlight Solutions Announces the Launch of AI Assist
16 avr. 2024 11h15 HE
|
Sunlight Solutions
Sunlight Solutions is pleased to announce the deployment of AI Assist, a toolkit that connects modern AI technologies to key insurance use cases.
Sunlight Solutions Announces 2023 Results
12 déc. 2023 14h51 HE
|
Sunlight Solutions
Sunlight Solutions is pleased to announce the company’s year-to-date (YTD) actual performance has eclipsed all projections for 2023.
New York State Approves Precipio’s HemeScreen for POL clinical use
18 nov. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
26 août 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
20 janv. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Precipio Adds Another HemeScreen™ Customer
09 juin 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 09, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted...
Precipio Launches New HemeScreen™ Reagent Rental Program
06 avr. 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 06, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program....
First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™
30 sept. 2019 11h10 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as...